For September 2019, we have selected two scientific papers with a common theme: Goadsby et al., Trial of galcanezumab in prevention of episodic cluster headache NEJM 2019; 381: 132-41, and Lipton et al., Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine NEJM 2019; 381: 142-9.

Switzerland is a beautiful country in the heart of Europe, stretching east to west from the lake of Constance to the lake of Geneva, and north to south from the river Rhine to the lago maggiore. Switzerland encompasses wonderful sceneries in the Alps, the middle lands and the Jura, which offer all kinds of outdoor activities in summer and winter, but also countless cultural events in his small but also metropolitan cities. Switzerland is a successful example that a multilingual and multicultural country can work. German, French, Italian and Roman are the national languages, and, with a population of 8.42 million inhabitants, Switzerland hosts more than 25% of foreign inhabitants from all over the world, all contributing to a beautiful, colorful and multicultural country, which regardless is deep-rooted in his traditions of independence, liberty, and direct democracy.

The European Medicines Agency has recommended that the multiple sclerosis medicine Gilenya (fingolimod) must not be used in pregnant women and in women able to have children who are not using effective contraception. If a woman becomes pregnant while using Gilenya, the medicine must be stopped and the pregnancy will have to be closely monitored. This is because the active substance in Gilenya, fingolimod, can harm the unborn baby and may cause birth defects.

Cognitive functioning and multimodal neuroimaging in narcolepsy type 1

During the Assembly of Delegates at the Oslo Congress, Professor Deuschl acknowledged Professor Hannah Cock’s longstanding tribute to EAN and her outstanding achievements in the Education Committee.

The Scientific Committee is fully committed to a great mission: To increase and share the best clinical knowledge and the cutting-edge information from translational research in all neurological fields. Main actions are i) to facilitate exchanges and synergies with the Scientific Panels ii) to support the Guideline Production Group (update and diffusion of expertise and best clinical practice), iii) to interact positively with other scientific societies with reciprocal exchanges and liaise with the European Affairs sub-Committee to increase the awareness of Neurology in Europe.

The purpose is to support training and experience for European Neurologists in any area of basic or clinical or applied research in neuroscience. The research work must be carried out at a European academic neurological department outside the country of residence. All applications should demonstrate experience/training of clear value to the home department/individual beyond that available in their own countries/institutions.   

News from other societies

Ahead of discussions on the new Multiannual Financial Framework (EU Budget for 2021-2027) during the European Council Summit on 20-21 June, the BioMed Alliance together with the EU Health Coalition partners published a statement advocating for a more substantial EU research budget.

Early Bird rates for the 29th Alzheimer Europe Conference (#29AEC) closed on 30 June 2019. Alzheimer Europe is delighted to announce that almost 600 delegates have already registered, with many more expected between now and close of online registrations, on 13 October 2019. The number of registrations so far has exceeded all previous years. Alzheimer Europe is excited to see everyone there, for what promises to be a diverse and engaging conference.

In this article, our goal is to provide a glimpse into the excellent collaboration and cooperation our organization has had with the European Federation of Neurorehabilitation Societies (EFNR).

Science|Business is canvassing views on the big research priorities for the next term of the EU, from 2019 to 2024. Here, six policy experts discuss the most pressing items on the EU’s to-do list for health.

Please find below articles from Italian authors that were published in the European Journal of Neurology.

Neuronet Scientific Coordination Board meeting brings together project leaders from across the IMI neurodegenerative disease portfolio, encompassing EUR 260 million of funding

The #BrainLifeGoals campaign is an initiative of the European Federation of Neurological Associations that aims to raise awareness of the impact of neurological disorders.